These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22530896)

  • 21. Discovery of ASP5286: A novel non-immunosuppressive cyclophilin inhibitor for the treatment of HCV.
    Makino T; Yoshimura S; Neya M; Yamanaka T; Sawada M; Tsujii E; Barrett D
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127308. PubMed ID: 32631528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus.
    Liu Y; Li J; Gu Y; Ma L; Cen S; Peng Z; Hu L
    Eur J Med Chem; 2022 Jan; 228():114033. PubMed ID: 34883293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.
    Zhang X; Zhang N; Chen G; Turpoff A; Ren H; Takasugi J; Morrill C; Zhu J; Li C; Lennox W; Paget S; Liu Y; Almstead N; Njoroge FG; Gu Z; Komatsu T; Clausen V; Espiritu C; Graci J; Colacino J; Lahser F; Risher N; Weetall M; Nomeir A; Karp GM
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3947-53. PubMed ID: 23683597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of ring A and/or C expansion and opening echinocystic acid derivatives for anti-HCV entry inhibitors.
    Wang H; Yu F; Peng Y; Wang Q; Han X; Xu R; Zhou X; Wan C; Fan Z; Jiao P; Zhang Y; Zhang L; Zhou D; Xiao S
    Eur J Med Chem; 2015 Sep; 102():594-9. PubMed ID: 26318066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM).
    Qin Z; Wang M; Yan A
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2931-2938. PubMed ID: 28501513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors.
    Hwang JY; Kim HY; Jo S; Park E; Choi J; Kong S; Park DS; Heo JM; Lee JS; Ko Y; Choi I; Cechetto J; Kim J; Lee J; No Z; Windisch MP
    Eur J Med Chem; 2013; 70():315-25. PubMed ID: 24177358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel symmetrical phenylenediamines as potential anti-hepatitis C virus agents.
    Bassetto M; Ferla S; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; O'Donnell R; Brancale A
    Antivir Chem Chemother; 2015 Dec; 24(5-6):155-160. PubMed ID: 27815332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiazole Compounds as Antiviral Agents: An Update.
    Singh IP; Gupta S; Kumar S
    Med Chem; 2020; 16(1):4-23. PubMed ID: 31203807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study.
    Du J; Bao D; Chun BK; Jiang Y; Reddy PG; Zhang HR; Ross BS; Bansal S; Bao H; Espiritu C; Lam AM; Murakami E; Niu C; Micolochick Steuer HM; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5924-9. PubMed ID: 22892115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents.
    Liu LJ; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):216-27. PubMed ID: 20408052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells.
    Shan GZ; Peng ZG; Li YH; Li D; Li YP; Meng S; Gao LY; Jiang JD; Li ZR
    J Antibiot (Tokyo); 2011 Feb; 64(2):177-82. PubMed ID: 21179047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2.
    Manvar D; Pelliccia S; La Regina G; Famiglini V; Coluccia A; Ruggieri A; Anticoli S; Lee JC; Basu A; Cevik O; Nencioni L; Palamara AT; Zamperini C; Botta M; Neyts J; Leyssen P; Kaushik-Basu N; Silvestri R
    Eur J Med Chem; 2015 Jan; 90():497-506. PubMed ID: 25483263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antiviral activity of a novel class of (5-oxazolyl)phenyl amines.
    Zhong ZJ; Zhang DJ; Peng ZG; Li YH; Shan GZ; Zuo LM; Wu LT; Li SY; Gao RM; Li ZR
    Eur J Med Chem; 2013 Nov; 69():32-43. PubMed ID: 23999140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bismacrocyclic inhibitors of hepatitis C NS3/4a protease.
    McCauley JA; Rudd MT; Nguyen KT; McIntyre CJ; Romano JJ; Bush KJ; Varga SL; Ross CW; Carroll SS; DiMuzio J; Stahlhut MW; Olsen DB; Lyle TA; Vacca JP; Liverton NJ
    Angew Chem Int Ed Engl; 2008; 47(47):9104-7. PubMed ID: 18925594
    [No Abstract]   [Full Text] [Related]  

  • 35. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
    Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamiridosins, hepatitis C virus entry inhibitors from Lamium album.
    Zhang H; Rothwangl K; Mesecar AD; Sabahi A; Rong L; Fong HH
    J Nat Prod; 2009 Dec; 72(12):2158-62. PubMed ID: 19904996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR and docking studies of HCV NS3 serine protease inhibitors.
    da Cunha EF; Matos KS; Ramalho TC
    Med Chem; 2013 Sep; 9(6):774-805. PubMed ID: 23140577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
    McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
    Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjugation of cyclodextrin with fullerene as a new class of HCV entry inhibitors.
    Xiao SL; Wang Q; Yu F; Peng YY; Yang M; Sollogoub M; Sinaÿ P; Zhang YM; Zhang LH; Zhou DM
    Bioorg Med Chem; 2012 Sep; 20(18):5616-22. PubMed ID: 22884577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and evolution of aloperine derivatives as a new family of HCV inhibitors with novel mechanism.
    Zhang X; Lv XQ; Tang S; Mei L; Li YH; Zhang JP; Jiang JD; Peng ZG; Song DQ
    Eur J Med Chem; 2018 Jan; 143():1053-1065. PubMed ID: 29232582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.